Abstract
Clenbuterol and other β-agonists are commonly misused as repartitioning agents in meat production and as doping substances to improve athletic performance. Numerous reports on food poisoning throughout Europe prompted the EU regulatory offices and FDA to implement a ban on the use of β-agonists as growth promoters. Several analytical methods have been developed for detecting illegal administration of these compounds, based mainly on chromatography and immunoassay screening. This article deals with the pharmacological aspect of β-agonists in growth promotion, control of their abuse and methods of analysis.
Keywords: clenbuterol, growth promotion, abuse, detection
Current Medicinal Chemistry
Title: Abuse of Clenbuterol and its Detection
Volume: 10 Issue: 4
Author(s): Andrej Prezelj, Ales Obreza and Slavko Pecar
Affiliation:
Keywords: clenbuterol, growth promotion, abuse, detection
Abstract: Clenbuterol and other β-agonists are commonly misused as repartitioning agents in meat production and as doping substances to improve athletic performance. Numerous reports on food poisoning throughout Europe prompted the EU regulatory offices and FDA to implement a ban on the use of β-agonists as growth promoters. Several analytical methods have been developed for detecting illegal administration of these compounds, based mainly on chromatography and immunoassay screening. This article deals with the pharmacological aspect of β-agonists in growth promotion, control of their abuse and methods of analysis.
Export Options
About this article
Cite this article as:
Prezelj Andrej, Obreza Ales and Pecar Slavko, Abuse of Clenbuterol and its Detection, Current Medicinal Chemistry 2003; 10 (4) . https://dx.doi.org/10.2174/0929867033368330
DOI https://dx.doi.org/10.2174/0929867033368330 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effects of Estrogen in the Brain: Is it a Neuroprotective Agent in Alzheimers Disease?
Current Aging Science Synthetic Androgens as Designer Supplements
Current Neuropharmacology Lysophosphatidic Acid and Renal Fibrosis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Nitric Oxide Control of Proliferation in Nerve Cells and in Tumor Cells of Nervous Origin
Current Pharmaceutical Design Imaging of Abdominal Aortic Aneurysm: The Present and the Future
Current Vascular Pharmacology Some Highlights on Epileptic EEG Processing
Recent Patents on Biomedical Engineering (Discontinued) Depressed Serum 25-Hydroxyvitamin D Levels Increase Hospital Stay and Alter Glucose Homeostasis in First-ever Ischemic Stroke
Current Neurovascular Research Cytokine-Directed Therapy in Asthma
Current Drug Targets - Inflammation & Allergy Strategies for Target-Specific Contrast Agents for Magnetic Resonance Imaging
Current Molecular Imaging (Discontinued) Utilizing Ultrasound to Transiently Increase Blood-Brain Barrier Permeability, Modulate of the Tight Junction Proteins, and Alter Cytoskeletal Structure
Current Neurovascular Research Heart Failure
Current Hypertension Reviews Combined Treatment Modalities for Age Related Macular Degeneration
Current Drug Targets Abnormalities of Peptide Metabolism in Alzheimer Disease
Current Neurovascular Research Integrating Virtual Screening Methods to the Quest for Novel Membrane Protein Ligands
Current Medicinal Chemistry - Central Nervous System Agents Editorial [ New Advances in Alzheimers Disease: From Biology to Therapy Guest Editor: Giuseppina Tesco ]
Current Genomics Patent Selections
Recent Patents on Nanotechnology Arundic Acid a Potential Neuroprotective Agent: Biological Development and Syntheses
Current Medicinal Chemistry New Technologies for the Diagnosis of Sleep Apnea
Current Hypertension Reviews Oral and Intra-nasal Administration of Nanoparticles in the Cerebral Ischemia Treatment in Animal Experiments: Considering its Advantages and Disadvantages
Current Clinical Pharmacology Simultaneous Monitoring of Febuxostat and Uric Acid in Human Serum Samples Using the Direct Square-Wave Voltammetric Method
Current Analytical Chemistry